BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10644735)

  • 41. Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation.
    Greenway AL; Dutartre H; Allen K; McPhee DA; Olive D; Collette Y
    J Virol; 1999 Jul; 73(7):6152-8. PubMed ID: 10364375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction with the Src homology (SH3-SH2) region of the Src-family kinase Hck structures the HIV-1 Nef dimer for kinase activation and effector recruitment.
    Alvarado JJ; Tarafdar S; Yeh JI; Smithgall TE
    J Biol Chem; 2014 Oct; 289(41):28539-53. PubMed ID: 25122770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
    Chen S; O'Reilly LP; Smithgall TE; Engen JR
    J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.
    Broome MA; Hunter T
    Oncogene; 1997 Jan; 14(1):17-34. PubMed ID: 9010229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains.
    Stanglmaier M; Warmuth M; Kleinlein I; Reis S; Hallek M
    Leukemia; 2003 Feb; 17(2):283-9. PubMed ID: 12592324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SH2- and SH3-mediated interactions between focal adhesion kinase and Src.
    Thomas JW; Ellis B; Boerner RJ; Knight WB; White GC; Schaller MD
    J Biol Chem; 1998 Jan; 273(1):577-83. PubMed ID: 9417118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.
    Merő B; Radnai L; Gógl G; Tőke O; Leveles I; Koprivanacz K; Szeder B; Dülk M; Kudlik G; Vas V; Cserkaszky A; Sipeki S; Nyitray L; Vértessy BG; Buday L
    J Biol Chem; 2019 Mar; 294(12):4608-4620. PubMed ID: 30659095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN; Fulton DB; Andreotti AH
    J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S; Burton EA; Wu SC; Anderson SM
    J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.
    Schindler T; Sicheri F; Pico A; Gazit A; Levitzki A; Kuriyan J
    Mol Cell; 1999 May; 3(5):639-48. PubMed ID: 10360180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
    Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
    Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.
    Trible RP; Emert-Sedlak L; Smithgall TE
    J Biol Chem; 2006 Sep; 281(37):27029-38. PubMed ID: 16849330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
    Hjermstad SJ; Briggs SD; Smithgall TE
    Biochemistry; 1993 Oct; 32(39):10519-25. PubMed ID: 7691175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system.
    Mandine E; Jean-Baptiste V; Vayssière B; Gofflo D; Bénard D; Sarubbi E; Deprez P; Baron R; Superti-Furga G; Lesuisse D
    Biochem Biophys Res Commun; 2002 Oct; 298(2):185-92. PubMed ID: 12387813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the SH3-SH2 domain linker sequence on the structure of Hck kinase.
    Meiselbach H; Sticht H
    J Mol Model; 2011 Aug; 17(8):1927-34. PubMed ID: 21110053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase.
    Grzesiek S; Bax A; Clore GM; Gronenborn AM; Hu JS; Kaufman J; Palmer I; Stahl SJ; Wingfield PT
    Nat Struct Biol; 1996 Apr; 3(4):340-5. PubMed ID: 8599760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn, and phosphatidylinositol 3-kinase.
    Anderson SM; Burton EA; Koch BL
    J Biol Chem; 1997 Jan; 272(2):739-45. PubMed ID: 8995358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.